Judge throws out Allergan patent, slams company’s Native American deal | Ars Technica:
"The ruling by US Circuit Judge William Bryson could have wide effects on the patent landscape because the Restasis patents are at the center of a novel legal strategy that involves using Native American sovereignty rights to avoid certain types of patent reviews, called inter partes reviews, or IPRs."
No comments:
Post a Comment